Literature DB >> 15026065

A prodrug approach to COX-2 inhibitors with methylsulfone.

Joo Hyun Moh1, Young Hoon Choi, Kyoung Min Lim, Ki-Wha Lee, Song Seok Shin, Jin Kyu Choi, Hyun Joo Koh, Shin Chung.   

Abstract

2,2-dimethyl-4-phenyl-5-[4-(methylsulfinyl)phenyl]-3(2H)furanone derivatives, 3 and 6, were shown to be effectively transformed in vivo into the corresponding methylsulfone derivatives 1 and 4, when orally administered to rats. Pharmacological implications for use of sulfoxide analogues 3 and 6 are discussed as prodrugs to potent selective COX-2 inhibitors 1 and 4.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026065     DOI: 10.1016/j.bmcl.2004.01.048

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  Open-label, randomized, controlled pilot study of the effects of a glucosamine complex on Low back pain.

Authors:  Laure Tant; Bruno Gillard; Thierry Appelboom
Journal:  Curr Ther Res Clin Exp       Date:  2005-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.